Membrane‐Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions
Autor: | Daniel T. Eitzman, Takeshi Akama, Richard H. Barnes, Julian C. Bahr, Miina K. Öhman, Stephen J. Weiss, Tae Hwa Chun, Moon Sook Woo |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Apolipoprotein E Male Smooth Muscle Proliferation and Differentiation Vascular smooth muscle muscle Mice Knockout ApoE Cell Communication Matrix metalloproteinase Muscle Smooth Vascular Extracellular matrix Genetically Altered and Transgenic Models Medicine Aorta Cells Cultured Original Research Metalloproteinase matrix metalloproteinases Plaque Atherosclerotic Cell biology Phenotype MMP14 Female medicine.symptom Inflammation Mediators Cardiology and Cardiovascular Medicine Extracellular Matrix Degradation smooth Signal Transduction Heterozygote Myocytes Smooth Muscle Aortic Diseases Inflammation Vascular Remodeling Iliac Artery Cell-Matrix Junctions 03 medical and health sciences Vascular Biology Matrix Metalloproteinase 14 Animals Genetic Predisposition to Disease Cell Proliferation business.industry Atherosclerosis Mice Inbred C57BL Disease Models Animal 030104 developmental biology inflammation Immunology aneurysm business Health Services and Outcomes Research |
Zdroj: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
ISSN: | 2047-9980 |
Popis: | Background The MMP (matrix metalloproteinase) family plays diverse and critical roles in directing vascular wall remodeling in atherosclerosis. Unlike secreted‐type MMP s, a member of the membrane‐type MMP family, MT 1‐ MMP (membrane‐type 1 MMP; MMP 14), mediates pericellular extracellular matrix degradation that is indispensable for maintaining physiological extracellular matrix homeostasis. However, given the premature mortality exhibited by MT 1‐ MMP –null mice, the potential role of the proteinase in atherogenesis remains elusive. We sought to determine the effects of both MT 1‐ MMP heterozygosity and tissue‐specific gene targeting on atherogenesis in APOE (apolipoprotein E)–null mice. Methods and Results MT 1‐ MMP heterozygosity in the APOE ‐null background ( Mmp14 +/− Apoe −/− ) significantly promoted atherogenesis relative to Mmp14 +/+ Apoe −/− mice. Furthermore, the tissue‐specific deletion of MT 1‐ MMP from vascular smooth muscle cells ( VSMC s) in SM 22α‐Cre(+) Mmp14 F/F Apoe −/− ( VSMC ‐knockout) mice likewise increased the severity of atherosclerotic lesions. Although VSMC ‐knockout mice also developed progressive atherosclerotic aneurysms in their iliac arteries, macrophage‐ and adipose‐specific MT 1‐ MMP –knockout mice did not display this sensitized phenotype. In VSMC ‐knockout mice, atherosclerotic lesions were populated by hyperproliferating VSMC s (smooth muscle actin– and Ki67–double‐positive cells) that were characterized by a proinflammatory gene expression profile. Finally, MT 1‐ MMP –null VSMC s cultured in a 3‐dimensional spheroid model system designed to mimic in vivo–like cell–cell and cell–extracellular matrix interactions, likewise displayed markedly increased proliferative potential. Conclusions MT 1‐ MMP expressed by VSMC s plays a key role in limiting the progression of atherosclerosis in APOE ‐null mice by regulating proliferative responses and inhibiting the deterioration of VSMC function in atherogenic vascular walls. |
Databáze: | OpenAIRE |
Externí odkaz: |